<![CDATA[In today's Wall Street Journal, there is a very interesting and insightful article entitled “Infectious Politics” that explains why flu vaccines in particular and vaccines for infectious diseases generally are in such short supply in the United States. The contributing factors appear to involve a combination of price controls, regulation and tort lawyers. Of course, I made the latter point (concerning tort) the other day in my blog entry entitled “Impact of the tort system on flu vaccine availability in the United States“.]]>
Published by Jim Garven
My name is Jim Garven. I currently hold appointments at Baylor University as the Frank S. Groner Memorial Chair of Finance and Professor of Finance & Insurance. I also currently serve as an associate editor for Geneva Risk and Insurance Review.
At Baylor, I teach courses in managerial economics, risk management, and financial engineering, and my research interests are in corporate risk management, insurance economics, and option pricing theory and applications.
Please email your comments about this weblog to James_Garven@baylor.edu.
View all posts by Jim Garven